SABBY MANAGEMENT, LLC - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 26 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$411,000
-41.8%
169,901
-31.2%
0.03%
-41.3%
Q2 2017$706,000246,9460.05%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Benin Management CORP 14,300$7,0000.00%
NORTHWEST WEALTH MANAGEMENT, LLC 4,000$2,0000.00%
Virtu Financial LLC 62,036$32,0000.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 20,000$10,0000.00%
Northeast Financial Consultants Inc 15,000$8,0000.00%
FRONTIER INVESTMENT MGMT CO 40,000$20,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 103,100$53,0000.00%
WEDBUSH SECURITIES INC 25,500$13,0000.00%
WELLS FARGO & COMPANY/MN 206$00.00%
NORTHERN TRUST CORP 99,691$51,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders